Results 11 to 20 of about 10,338 (183)

Cytochrome P450 Enzymes Involved in Metoprolol Metabolism and Use of Metoprolol as a CYP2D6 Phenotyping Probe Drug [PDF]

open access: yesFrontiers in Pharmacology, 2018
Metoprolol is used for phenotyping of cytochrome P450 (CYP) 2D6, a CYP isoform considered not to be inducible by inducers of the CYP2C, CYP2B, and CYP3A families such as rifampicin.
Benjamin Berger   +10 more
doaj   +4 more sources

Quercetin declines plasma exposure of metoprolol tartrate in the rat model

open access: yesJournal of Advanced Pharmaceutical Technology & Research, 2014
The study was undertaken to evaluate the effect of quercetin on the pharmacokinetics of Metoprolol tartrate. A single dose in vivo pharmacokinetic study was carried out in rat models.
Siva R Challa   +2 more
doaj   +2 more sources

Nociceptive Effects of Locally Treated Metoprolol

open access: yesÇukurova Üniversitesi Tıp Fakültesi Dergisi, 2015
Purpose: Beta (beta-)-adrenergic receptor antagonists, such as metoprolol, are often used to avoid circulatory complications during anesthesia for their antihypertensive and anti-tachycardia effects in patients with cardiovascular diseases.
Nursima Cukadar   +6 more
doaj   +2 more sources

Impact of amiodarone use on metoprolol concentrations, α‐OH‐metoprolol concentrations, metoprolol dosing and heart rate: A cross‐sectional study

open access: yesPharmacology Research & Perspectives, 2023
Small studies suggest that amiodarone is a weak inhibitor of cytochrome P450 (CYP) 2D6. Inhibition of CYP2D6 leads to increases in concentrations of drugs metabolized by the enzyme, such as metoprolol. Considering that both metoprolol and amiodarone have
Sabrina Robert   +11 more
doaj   +1 more source

Baseline Corrected QT Interval Dispersion Is Useful to Predict Effectiveness of Metoprolol on Pediatric Postural Tachycardia Syndrome

open access: yesFrontiers in Cardiovascular Medicine, 2022
ObjectivesThe study was designed to explore the role of baseline-corrected QT interval dispersion (QTcd) in predicting the effectiveness of metoprolol on pediatric postural tachycardia syndrome (POTS).MethodsThere were two groups in the study, the ...
Yuanyuan Wang   +10 more
doaj   +1 more source

Effects of pre-treatment with metoprolol and diltiazem on cerebral ischemia/reperfusion-induced injuries

open access: yesBrazilian Journal of Pharmaceutical Sciences, 2023
Stroke is one of the most important health concerns worldwide. Calcium ions accumulation in the nerve cells and increase in the catecholamines level of the brain following cerebral ischemia/reperfusion (I/R) are accompanied by damaging effects. Therefore,
Ghazaleh Sadrhaghighi   +4 more
doaj   +1 more source

Metabolomic profiling of metoprolol hypertension treatment reveals altered gut microbiota-derived urinary metabolites

open access: yesHuman Genomics, 2020
Introduction Metoprolol succinate is a long-acting beta-blocker prescribed for the management of hypertension (HTN) and other cardiovascular diseases.
Chad N. Brocker   +9 more
doaj   +1 more source

Interaction of Palmitic Acid with Metoprolol Succinate at the Binding Sites of Bovine Serum Albumin [PDF]

open access: yesAdvanced Pharmaceutical Bulletin, 2014
Purpose: The aim of this study was to characterize the binding profile as well as to notify the interaction of palmitic acid with metoprolol succinate at its binding site on albumin.
Mashiur Rahman   +3 more
doaj   +1 more source

Metoprolol physiological based pharmacokinetics model (PBPK)

open access: yes, 2021
This repository provides the metoprolol physiological based pharmacokinetics/pharmacodynamics model (PBPK/PD). If you have any questions or problems please open an issue FundingMatthias König is supported by the Federal Ministry of Education and Research
König, Matthias, Ogata, Paula
core   +1 more source

Metoprolol rescues endothelial progenitor cell dysfunction in diabetes [PDF]

open access: yesPeerJ, 2020
Added risk portended by diabetes in addition to hypertension has been related to an amplification of endothelial dysfunction. β-blockers are widely used for cardiovascular diseases and improve the endothelial function compared with a placebo.
Lang Yan   +12 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy